Delivery Order SPE2DB20D1100-SPE2DB25FE0W7
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Jardiance 10 mg tablets (90-count units) under a firm fixed-price contract valued at $11,743.92, with an ultimate completion date of July 28, 2025. This non-set-aside competitive award represents a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, a $999.99 billion prime vendor agreement running through...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of Jardiance 10 mg tablets (90-count units) with a ceiling value of $9,798.71. This competitive, non-set-aside award is structured as a firm fixed price delivery order with an ultimate completion date of August 11, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Jardiance 25 mg tablets (90-count packages) valued at $10,494.63. The contract is a firm fixed price delivery order with no set-aside designation, indicating competitive award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal medical procurement needs, particularly for military and veteran...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Jardiance 10 mg tablets (90-count supply) under a firm fixed-price contract valued at $21,457.04. This delivery order, which is non-set-aside and competitively awarded, is scheduled for completion by July 31, 2025, with performance taking place at the contractor's Conshohocken, Pennsylvania location. AmerisourceBergen Drug Corp, a major pharmaceutical...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $12,130.81 on July 31, 2025, for the supply of Jardiance 25 mg tablets (90-count units). This firm fixed-price, competitively awarded contract has an ultimate completion date of August 1, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Jardiance 25 mg tablets (90-count units) with a ceiling value of $3,289.88 under firm fixed pricing. This contract is a child award issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The award is non-set-aside and was competitively awarded, with the place of...
- The Defense Logistics Agency awarded a $19,435.63 delivery order to AmerisourceBergen Drug Corp for the supply of Jardiance 10 mg tablets (90-count) on July 28, 2025, with an ultimate completion date of July 29, 2025. This firm fixed price contract was awarded competitively with no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a $3,018.22 firm fixed-price delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Jardiance 25 mg tablets (90-count units). The contract, which is not set-aside, will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 15, 2025. This delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Jardiance 25 mg tablets (90-count units) valued at $12,698.24 under a firm fixed price contract. This award represents a child delivery order executed against AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a ceiling value of $999,999,999.00 and extends through December 2026. The delivery order is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 1, 2025, for the supply of Jardiance 10 mg tablets in a quantity of 90 units, with a contract ceiling value of $4,440.03. This is a firm fixed price delivery order with an ultimate completion date of August 4, 2025, and represents a non-set-aside competitive award. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...
- SPE2DB20D1100Indefinite Delivery Contract
- SPE2DB20D1100-SPE2DB25FE0W7Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Jardiance 10 mg tablets (90-count) under a firm fixed-price contract valued at $8,585.13. The order is scheduled for completion by August 15, 2025, and will be fulfilled from the contractor's location in Conshohocken, Pennsylvania. This delivery order represents a non-set-aside, competitively awarded transaction and is issued as a child contract under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a $999,999,999.00 ceiling value through December 2026. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. The company's comprehensive IDC with DLA enables it to supply a broad range of pharmaceutical products and medical commodities globally, including brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains. This delivery order for Jardiance—a diabetes medication—exemplifies the company's role in supplying essential pharmaceutical products to the Defense Health Agency and other federal healthcare customers through flexible contract vehicles designed to meet diverse medical supply requirements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.6k | 8/14/25 |